Gastroesophageal Reflux Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Global Gastroesophageal Reflux Disease (GERD) Market Trends & Growth and it is Segmented by Diagnosis (Upper Endoscopy, Ambulatory Acid (pH) Probe Test, Esophageal Manometry, and Others), Drug Type (Proton Pump Inhibitors (PPIs), H2 Receptor Blockers, and Others), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market provides the value (in USD million) for the above segments.

Gastroesophageal Reflux Disease Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Gastroesophageal Reflux Disease (GERD) Industry Overview

The gastroesophageal reflux disease market is fragmented in nature owing to the presence of several market players. The market players are engaged in strategic initiatives such as mergers, acquisitions, product approvals, and launches to expand their presence. Some of the market players are Pfizer, Inc., Johnson & Johnson, SRS Life Sciences, Takeda Pharmaceutical Co., Ltd., and Haleon Group of Companies.

Gastroesophageal Reflux Disease (GERD) Market Leaders

  1. Pfizer, Inc.

  2. Johnson & Johnson

  3. SRS Life Sciences

  4. Takeda Pharmaceutical Co., Ltd.

  5. Haleon Group of Companies

  6. *Disclaimer: Major Players sorted in no particular order
Gastroesophageal Reflux Disease Market Concentration

Gastroesophageal Reflux Disease Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?